Related references
Note: Only part of the references are listed.Discovery of novel DprE1 inhibitors via computational bioactivity fingerprints and structure-based virtual screening
Xue-ping Hu et al.
ACTA PHARMACOLOGICA SINICA (2022)
Efficient Synthesis of Benzothiazinone Analogues with Activity against Intracellular Mycobacterium tuberculosis
Adrian Richter et al.
CHEMMEDCHEM (2022)
Exploring disordered loops in DprE1 provides a functional site to combat drug-resistance in Mycobacterium strains
Jiyuan Liu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)
The Veterinary Anti-Parasitic Selamectin Is a Novel Inhibitor of the Mycobacterium tuberculosis DprE1 Enzyme
Jose Manuel Ezquerra-Aznarez et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Identification of thiophene-benzenesulfonamide derivatives for the treatment of multidrug-resistant tuberculosis
Rongfei Qin et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)
Development of Predictive Classification Models for Whole Cell Antimycobacterial Activity of Benzothiazinones
Sebastian Schieferdecker et al.
JOURNAL OF MEDICINAL CHEMISTRY (2022)
Development of 6-Methanesulfonyl-8-nitrobenzothiazinone Based Antitubercular Agents
Rui Shi et al.
ACS MEDICINAL CHEMISTRY LETTERS (2022)
Identification of novel benzothiopyranones with ester and amide motifs derived from active metabolite as promising leads against Mycobacterium tuberculosis
Peng Li et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
8-cyanobenzothiazinone analogs with potent antitubercular activity
Gang Zhang et al.
MEDICINAL CHEMISTRY RESEARCH (2021)
Structural and Activity Relationships of 6-Sulfonyl-8-Nitrobenzothiazinones as Antitubercular Agents
Dongguang Fan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Discovery of Novel Thiophene-arylamide Derivatives as DprE1 Inhibitors with Potent Antimycobacterial Activities
Pengxu Wang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Tuberculosis Drug Discovery: A Decade of Hit Assessment for Defined Targets
Sangmi Oh et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)
Comparative Analysis of Pharmacodynamics in the C3HeB/FeJ Mouse Tuberculosis Model for DprE1 Inhibitors TBA-7371, PBTZ169, and OPC-167832
Gregory T. Robertson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)
Design, synthesis and biological activity of N-(amino)piperazine-containing benzothiazinones against Mycobacterium tuberculosis
Apeng Wang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Synthesis, structural characterization and antimycobacterial evaluation of several halogenated non-nitro benzothiazinones
Balungile Madikizela et al.
MEDICINAL CHEMISTRY RESEARCH (2021)
Chemical Space Exploration of DprE1 Inhibitors Using Chemoinformatics and Artificial Intelligence
Sonali Chhabra et al.
ACS OMEGA (2021)
The quest for the holy grail: new antitubercular chemical entities, targets and strategies
Stanislav Huszar et al.
DRUG DISCOVERY TODAY (2020)
Mycobacterium tuberculosis Decaprenylphosphoryl-β-D-ribose Oxidase Inhibitors: Expeditious Reconstruction of Suboptimal Hits into a Series with Potent in Vivo Activity
Jennifer A. Borthwick et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Treatment of Highly Drug-Resistant Pulmonary Tuberculosis
Francesca Conradie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
OPC-167832, a Novel Carbostyril Derivative with Potent Antituberculosis Activity as a DprE1 Inhibitor
Norimitsu Hariguchi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Promiscuous Targets for Antitubercular Drug Discovery: The Paradigm of DprE1 and MmpL3
Giulia Degiacomi et al.
APPLIED SCIENCES-BASEL (2020)
Molecule Property Analyses of Active Compounds for Mycobacterium tuberculosis
Vadim Makarov et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Facts, Patterns, and Principles in Drug Discovery: Appraising the Rule of 5 with Measured Physicochemical Data
Christopher P. Tinworth et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Optimization of Hydantoins as Potent Antimycobacterial Decaprenylphosphoryl-β-D-Ribose Oxidase (DprE1) Inhibitors
Olga Balabon et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Identification of 2-((2,3-dihydrobenzo [b] [1,4] dioxin-6-yl)amino)-N-phenylpropanamides as a novel class of potent DprE1 inhibitors
Benjamin C. Whitehurst et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2020)
Identification of benzothiazinones containing 2-benzyl-2,7-diazaspiro [3.5]nonane moieties as new antitubercular agents
Apeng Wang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
hERG toxicity assessment: Useful guidelines for drug design
Amanda Garrido et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Design, synthesis and antimycobacterial activity of new benzothiazinones inspired by rifampicin/rifapentine
Apeng Wang et al.
BIOORGANIC CHEMISTRY (2020)
Design, synthesis and evaluation of covalent inhibitors of DprE1 as antitubercular agents
Lingfeng Liu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Identification of benzothiazones containing a hexahydropyrrolo[3,4-c]pyrrol moiety as antitubercular agents against MDR-MTB
Xican Ma et al.
RSC ADVANCES (2020)
Design, synthesis and antimycobacterial activity of novel nitrobenzamide derivatives
Hongjian Wang et al.
CHINESE CHEMICAL LETTERS (2019)
Spirocyclic and Bicyclic 8-Nitrobenzothiazinones for Tuberculosis with Improved Physicochemical and Pharmacokinetic Properties
Gang Zhang et al.
ACS MEDICINAL CHEMISTRY LETTERS (2019)
Design, synthesis, antitubercular and antibacterial activities of pyrrolo[3,2-b]pyridine-3-carboxamide linked 2-methoxypyridine derivatives and in silico docking studies
Srinu Bodige et al.
SYNTHETIC COMMUNICATIONS (2019)
Development of 3,5-Dinitrophenyl-Containing 1,2,4-Triazoles and Their Trifluoromethyl Analogues as Highly Efficient Antitubercular Agents Inhibiting Decaprenylphosphoryl-β-D-ribofuranose 2′-Oxidase
Galina Karabanovich et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Design, synthesis and biological evaluation of some 2-(6-nitrobenzo[d]thiazol-2-ylthio)-N-benzyl-N-(6-nitrobenzo[d]thiazol-2-yl)acetamide derivatives as selective DprE1 inhibitors
Jineetkumar Gawad et al.
SYNTHETIC COMMUNICATIONS (2019)
Deuteration of BTZ043 Extends the Lifetime of Meisenheimer Intermediates to the Antituberculosis Nitroso Oxidation State
Rui Liu et al.
ACS MEDICINAL CHEMISTRY LETTERS (2019)
Scaffold Morphing To Identify Novel DprE1 Inhibitors with Antimycobacterial Activity
M. R. Manjunatha et al.
ACS MEDICINAL CHEMISTRY LETTERS (2019)
hERG optimizations of IMB1603, discovery of alternative benzothiazinones as new antitubercular agents
Kai Lv et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Identification of benzothiazinones containing an oxime functional moiety as new anti-tuberculosis agents
Apeng Wang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Nitro-Group-Containing Drugs
Kunal Nepali et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Structure-Based Drug Design and Characterization of Sulfonyl-Piperazine Benzothiazinone Inhibitors of DprE1 from Mycobacterium tuberculosis
Jeremie Piton et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Metabolism of SKLB-TB1001, a Potent Antituberculosis Agent, in Animals
Lu Xiong et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Hit Generation in TB Drug Discovery: From Genome to Granuloma
Tianao Yuan et al.
CHEMICAL REVIEWS (2018)
Therapeutic potential of promiscuous targets in Mycobacterium tuberculosis
Bei Shi Lee et al.
CURRENT OPINION IN PHARMACOLOGY (2018)
Drug discovery in tuberculosis. New drug targets and antimycobacterial agents
Andre Campanico et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Design, synthesis and antitubercular evaluation of benzothiazinones containing a piperidine moiety
Kai Lv et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Overview of the Development of DprE1 Inhibitors for Combating the Menace of Tuberculosis
Rupesh V. Chikhale et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Identification of N-Benzyl 3,5-Dinitrobenzamides Derived from PBTZ169 as Antitubercular Agents
Linhu Li et al.
ACS MEDICINAL CHEMISTRY LETTERS (2018)
Identification of a new series of benzothiazinone derivatives with excellent antitubercular activity and improved pharmacokinetic profiles
Lu Xiong et al.
RSC ADVANCES (2018)
Identification of novel benzothiopyranone compounds against Mycobacterium tuberculosis through scaffold morphing from benzothiazinones
Peng Li et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
A large comparison of integrated SAR/QSAR models of the Ames test for mutagenicity($)
E. Benfenati et al.
SAR AND QSAR IN ENVIRONMENTAL RESEARCH (2018)
Novel insight into the reaction of nitro, nitroso and hydroxylamino benzothiazinones and of benzoxacinones with Mycobacterium tuberculosis DprE1
Adrian Richter et al.
SCIENTIFIC REPORTS (2018)
Fluorescent Benzothiazinone Analogues Efficiently and Selectively Label Dpre1 in Mycobacteria and Actinobacteria
Raphael Sommer et al.
ACS CHEMICAL BIOLOGY (2018)
Identification and Profiling of Hydantoins-A Novel Class of Potent Antimycobacterial DprE1 Inhibitors
Maciej K. Rogacki et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Discovery and Structure-Activity-Relationship Study of N-Alkyl-5-hydroxypyrimidinone Carboxamides as Novel Antitubercular Agents Targeting Decaprenylphosphoryl-beta-D-ribose 2 '-Oxidase
Sangmi Oh et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Seven Year Itch: Pan-Assay Interference Compounds (PAINS) in 2017-Utility and Limitations
Jonathan B. Baell et al.
ACS CHEMICAL BIOLOGY (2018)
Phantom PAINS: Problems with the Utility of Alerts for Pan-Assay INterference CompoundS
Stephen J. Capuzzi et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2017)
How Frequently Are Pan-Assay Interference Compounds Active? Large-Scale Analysis of Screening Data Reveals Diverse Activity Profiles, Low Global Hit Frequency, and Many Consistently Inactive Compounds
Swarit Jasial et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Identification of Better Pharmacokinetic Benzothiazinone Derivatives as New Antitubercular Agents
Kai Lv et al.
ACS MEDICINAL CHEMISTRY LETTERS (2017)
Design, synthesis and antitubercular evaluation of benzothiazinones containing an oximido or amino nitrogen heterocycle moiety
Rui Zhang et al.
RSC ADVANCES (2017)
Computational analysis of calculated physicochemical and ADMET properties of protein-protein interaction inhibitors
David Lagorce et al.
SCIENTIFIC REPORTS (2017)
Determinants of the Inhibition of DprE1 and CYP2C9 by Antitubercular Thiophenes
Renhe Liu et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2017)
Structural studies of Mycobacterium tuberculosis DprE1 interacting with its inhabitors
Jeremie Piton et al.
DRUG DISCOVERY TODAY (2017)
Pharmacogenomics of the cytochrome P450 2C family: impacts of amino acid variations on drug metabolism
Adriana Isvoran et al.
DRUG DISCOVERY TODAY (2017)
How Beyond Rule of 5 Drugs and Clinical Candidates Bind to Their Targets
Bradley C. Doak et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Molecular inflation, attrition and the rule of five
Paul D. Leeson
ADVANCED DRUG DELIVERY REVIEWS (2016)
Rule of five in 2015 and beyond: Target and ligand structural limitations, ligand chemistry structure and drug discovery project decisions
Christopher A. Lipinski
ADVANCED DRUG DELIVERY REVIEWS (2016)
Cell permeability beyond the rule of 5
Par Matsson et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Nitroarenes as Antitubercular Agents: Stereoelectronic Modulation to Mitigate Mutagenicity
Sudhir Landge et al.
CHEMMEDCHEM (2016)
Design, Syntheses, and Anti-TB Activity of 1,3-Benzothiazinone Azide and Click Chemistry Products Inspired by BTZ043
Rohit Tiwari et al.
ACS MEDICINAL CHEMISTRY LETTERS (2016)
Tuberculosis
Madhukar Pai et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Benzothiazinethione is a potent preclinical candidate for the treatment of drug-resistant tuberculosis
Chao Gao et al.
SCIENTIFIC REPORTS (2016)
DprE1 Is a Vulnerable Tuberculosis Drug Target Due to Its Cell Wall Localization
Miroslav Brecik et al.
ACS CHEMICAL BIOLOGY (2015)
In vitro, in silico and integrated strategies for the estimation of plasma protein binding. A review
George Lambrinidis et al.
ADVANCED DRUG DELIVERY REVIEWS (2015)
The 8-Pyrrole-Benzothiazinones Are Noncovalent Inhibitors of DprE1 from Mycobacterium tuberculosis
Vadim Makarov et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Discovery of benzothiazoles as antimycobacterial agents: Synthesis, structure-activity relationships and binding studies with Mycobacterium tuberculosis decaprenylphosphoryl-β-D-ribose 2′-oxidase
Sudhir Landge et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Synthesis and antitubercular evaluation of 4-carbonyl piperazine substituted 1,3-benzothiazin-4-one derivatives
Cui-Ting Peng et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
Development of selective DprE1 inhibitors: Design, synthesis, crystal structure and antitubercular activity of benzothiazolylpyrimidine-5-carboxamides
Rupesh Chikhale et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Treatment of Tuberculosis
C. Robert Horsburgh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Whole Cell Target Engagement Identifies Novel Inhibitors of Mycobacterium tuberculosis Decaprenylphosphoryl-β-D-ribose Oxidase
Sarah M. Batt et al.
ACS INFECTIOUS DISEASES (2015)
2-Carboxyquinoxalines Kill Mycobacterium tuberculosis through Noncovalent Inhibition of DprE1
Joao Neres et al.
ACS CHEMICAL BIOLOGY (2015)
Syntheses and Antituberculosis Activity of 1,3-Benzothiazinone Sulfoxide and Sulfone Derived from BTZ043
Rohit Tiwari et al.
ACS MEDICINAL CHEMISTRY LETTERS (2015)
1,4-Azaindole, a Potential Drug Candidate for Treatment of Tuberculosis
Monalisa Chatterji et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Oral Druggable Space beyond the Rule of 5: Insights from Drugs and Clinical Candidates
Bradley Croy Doak et al.
CHEMISTRY & BIOLOGY (2014)
Towards a new combination therapy for tuberculosis with next generation benzothiazinones
Vadim Makarov et al.
EMBO MOLECULAR MEDICINE (2014)
Tuberculosis drug discovery in the post-post-genomic era
Benoit Lechartier et al.
EMBO MOLECULAR MEDICINE (2014)
Sulfur rich 2-mercaptobenzothiazole and 1,2,3-triazole conjugates as novel antitubercular agents
Fauzia Mir et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Lead Optimization of 1,4-Azaindoles as Antimycobacterial Agents
Pravin S. Shirude et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
4-Aminoquinolone Piperidine Amides: Noncovalent Inhibitors of DprE1 with Long Residence Time and Potent Antimycobacterial Activity
Maruti Naik et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Discovery of Pyrazolopyridones as a Novel Class of Noncovalent DprE1 Inhibitor with Potent Anti-Mycobacterial Activity
Manoranjan Panda et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Assessing the essentiality of the decaprenyl-phospho-D-arabinofuranose pathway in Mycobacterium tuberculosis using conditional mutants
Gaelle S. Kolly et al.
MOLECULAR MICROBIOLOGY (2014)
How sisters grow apart: mycobacterial growth and division
Karen J. Kieser et al.
NATURE REVIEWS MICROBIOLOGY (2014)
Synthesis and biological evaluation of substituted N-alkylphenyl-3,5-dinitrobenzamide analogs as anti-TB agents
Gurunadham Munagala et al.
MEDCHEMCOMM (2014)
The DprE1 enzyme, one of the most vulnerable targets of Mycobacterium tuberculosis
Giovanna Riccardi et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2013)
Synthesis and structure-activity relationships evaluation of benzothiazinone derivatives as potential anti-tubercular agents
Chao Gao et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Fueling Open-Source Drug Discovery: 177 Small-Molecule Leads against Tuberculosis
Lluis Ballell et al.
CHEMMEDCHEM (2013)
Broad Coverage of Commercially Available Lead-like Screening Space with Fewer than 350,000 Compounds
Jonathan B. Baell
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2013)
Azaindoles: Noncovalent DprE1 Inhibitors from Scaffold Morphing Efforts, Kill Mycobacterium tuberculosis and Are Efficacious in Vivo
Pravin S. Shirude et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Thiolates Chemically Induce Redox Activation of BTZ043 and Related Potent Nitroaromatic Anti-Tuberculosis Agents
Rohit Tiwari et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2013)
Advances in the development of new tuberculosis drugs and treatment regimens
Alimuddin Zumla et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
Ulrich M. Zanger et al.
PHARMACOLOGY & THERAPEUTICS (2013)
Identification of a small molecule with activity against drug-resistant and persistent tuberculosis
Feng Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Identification of Novel Inhibitors of M. tuberculosis Growth Using Whole Cell Based High-Throughput Screening
Sarah A. Stanley et al.
ACS CHEMICAL BIOLOGY (2012)
ChemBioServer: a web-based pipeline for filtering, clustering and visualization of chemical compounds used in drug discovery
Emmanouil Athanasiadis et al.
BIOINFORMATICS (2012)
Toward in silico structure-based ADMET prediction in drug discovery
Gautier Moroy et al.
DRUG DISCOVERY TODAY (2012)
Integrated in silico approaches for the prediction of Ames test mutagenicity
Sandeep Modi et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2012)
Identification of Antitubercular Benzothiazinone Compounds by Ligand-Based Design
Tomislav Karoli et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Benzothiazinones Are Suicide Inhibitors of Mycobacterial Decaprenylphosphoryl-β-D-ribofuranose 2′-Oxidase DprE1
Claudia Trefzer et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2012)
Structural basis of inhibition of Mycobacterium tuberculosis DprE1 by benzothiazinone inhibitors
Sarah M. Batt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Structural Basis for Benzothiazinone-Mediated Killing of Mycobacterium tuberculosis
Joao Neres et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Improving Drug Candidates by Design: A Focus on Physicochemical Properties As a Means of Improving Compound Disposition and Safety
Nicholas A. Meanwell
CHEMICAL RESEARCH IN TOXICOLOGY (2011)
Getting physical in drug discovery II: the impact of chromatographic hydrophobicity measurements and aromaticity
Robert J. Young et al.
DRUG DISCOVERY TODAY (2011)
Decaprenylphosphoryl-β-D-Ribose 2′-Epimerase, the Target of Benzothiazinones and Dinitrobenzamides, Is an Essential Enzyme in Mycobacterium smegmatis
Paul K. Crellin et al.
PLOS ONE (2011)
Intramolecular hydrogen bonding to improve membrane permeability and absorption in beyond rule of five chemical space
Alexander Alex et al.
MEDCHEMCOMM (2011)
Clinical Isolates of Mycobacterium tuberculosis in Four European Hospitals Are Uniformly Susceptible to Benzothiazinones
Maria Rosalia Pasca et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Getting physical in drug discovery: a contemporary perspective on solubility and hydrophobicity
Alan P. Hill et al.
DRUG DISCOVERY TODAY (2010)
Lipophilicity in drug discovery
Michael J. Waring
EXPERT OPINION ON DRUG DISCOVERY (2010)
New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays
Jonathan B. Baell et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Benzothiazinones: Prodrugs That Covalently Modify the Decaprenylphosphoryl-β-D-ribose 2′-epimerase DprE1 of Mycobacterium tuberculosis
Claudia Trefzer et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)
Assessment of the blood-brain barrier in CNS drug discovery
Phil Jeffrey et al.
NEUROBIOLOGY OF DISEASE (2010)
Leads for antitubercular compounds from kinase inhibitor library screens
Sophie Magnet et al.
TUBERCULOSIS (2010)
Defining optimum lipophilicity and molecular weight ranges for drug candidates-Molecular weight dependent lower logD limits based on permeability
Michael J. Waring
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
hERG-related drug toxicity and models for predicting hERG liability and QT prolongation
Emanuel Raschi et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2009)
2-Substituted-4,5-Dihydroxypyrimidine-6-Carboxamide Antiviral Targeted Libraries
Vincent A. Boyd et al.
JOURNAL OF COMBINATORIAL CHEMISTRY (2009)
Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis
Vadim Makarov et al.
SCIENCE (2009)
Antituberculosis activity of the molecular libraries screening center network library
Joseph A. Maddry et al.
TUBERCULOSIS (2009)
Discovery and validation of new antitubercular compounds as potential drug leads and probes
Robert C. Goldman et al.
TUBERCULOSIS (2009)
High-throughput screening for inhibitors of Mycobacterium tuberculosis H37Rv
Subramaniam Ananthan et al.
TUBERCULOSIS (2009)
High Content Screening Identifies Decaprenyl-Phosphoribose 2′ Epimerase as a Target for Intracellular Antimycobacterial Inhibitors
Thierry Christophe et al.
PLOS PATHOGENS (2009)
Physiochemical drug properties associated with in vivo toxicological outcomes
Jason D. Hughes et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Biosynthesis of D-arabinose in mycobacteria - a novel bacterial pathway with implications for antimycobacterial therapy
Beata A. Wolucka
FEBS JOURNAL (2008)
Generation of a set of simple, interpretable ADMET rules of thumb
M. Paul Gleeson
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Predicting intrinsic aqueous solubility by a thermodynamic cycle
David S. Palmer et al.
MOLECULAR PHARMACEUTICS (2008)
ADMET property prediction: The state of the art and current challenges
Joelle Gola et al.
QSAR & COMBINATORIAL SCIENCE (2006)
Transfer of a point mutation in Mycobacterium tuberculosis inhA resolves the target of isoniazid
Catherine Vilcheze et al.
NATURE MEDICINE (2006)
A model for identifying HERG K+ channel blockers
AM Aronov et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2004)
Time-related differences in the physical property profiles of oral drugs
PD Leeson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
A comparison of physiochemical property profiles of development and marketed oral drugs
MC Wenlock et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Toward a pharmacophore for drugs inducing the long QT syndrome:: Insights from a CoMFA study of HERG K+ channel blockers
A Cavalli et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties
P Ertl et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
Mutagenicity of nitroaromatic compounds
V Purohit et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2000)
Drug-like properties and the causes of poor solubility and poor permeability
CA Lipinski
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2000)
Share Paper
